03 November 2022 | Paul Dixey
Investing in Biotech
In episode 18, Paul is joined by Dr Daniel Koller, head of the investment management team at Bellevue Asset Management, one of the largest, specialist Biotech investors in the world. They talk about the incredibly exciting and innovative sector that is Biotech. Daniel explains the long-term growth drivers underpinning the sector, why the US do Biotech so well and some applications of the ground-breaking mRNA technology and genome editing.